Eiger Biopharmaceuticals Inc (EIGR) Return on Assets ROA from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Eiger Biopharmaceuticals Inc   (NASDAQ: EIGR)


Eiger Biopharmaceuticals Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Eiger Biopharmaceuticals Inc 's ROA in the fourth quarter of 2023?
Eiger Biopharmaceuticals Inc recorded a cumulative net loss of $-75 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -112.7%.

However, within the Healthcare sector 982 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 4922 to 5524.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change -67.68 % -61.28 % -55.8 % -35.28 % -42.86 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -75 -87 -96 -97 -97
Return On Assets (TTM) -112.7 % -99.77 % -87.93 % -73.59 % -66.64 %
EIGR's Total Ranking # 5524 # 4922 # 4953 # 4987 # 5685
Total Assets (TTM) in million 39 56 72 99 120
Seq. Total Assets Change -30.24 % -23.09 % -27.08 % -17.41 % -16.42 %
Seq. Net Income Change - - - - -

EIGR's 5 Years Annual ROA >> Back to EIGR Management Effectiveness >> Compare EIGR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 157
Sector # 983
Overall # 5403

Return On Assets Statistics
High Average Low
-14.61 %
-66.65 %
-169.81 %
(Mar 31 2021)   (Sep 30 2017)





Financial Statements
Eiger Biopharmaceuticals Inc 's Assets $ 39 million EIGR's Balance sheet
Eiger Biopharmaceuticals Inc 's Income $ -13 million Quarterly EIGR's Income Statement
EIGR's Income by Division See EIGR's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change -67.68 % -4.95 % -11.92 % 36.5 % 2.63 %
Total Assets in million 39 120 126 144 105
Y / Y Net Income Change - - - - -
Net Income in million -75 -97 -34 -65 -70
Annual Return On Assets -193.07 % -80.55 % -26.83 % -45.33 % -66.82 %

EIGR's 5 Years Annual ROA >> Back to EIGR Management Effectiveness >> Compare EIGR ROA to its Competitors



More Return On Assets Ratios
EIGR's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EIGR's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EIGR's Competitors
Subscribers only: Roa for Eiger Biopharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for EIGR's Customers

You may also want to know
EIGR's Roi EIGR's Inventory Turnover Ratio EIGR's Growth Rates EIGR's Dividend Comparisons
EIGR's Profitability Ratios EIGR's Asset Turnover Ratio EIGR's Dividend Growth
EIGR's Roe EIGR's Valuation Ratios EIGR's Financial Strength Ratios EIGR's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA

Date modified: 2026-09-18T14:07:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.